Prostatype Genomics AB (publ) (STO:PROGEN)
0.5400
+0.0950 (21.35%)
Jun 5, 2026, 5:29 PM CET
Prostatype Genomics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.07 | 9.42 | 2.68 | 4.81 | 9.83 |
Short-Term Investments | - | - | - | 6.68 | 10.5 |
Cash & Short-Term Investments | 9.07 | 9.42 | 2.68 | 11.49 | 20.33 |
Cash Growth | -3.74% | 251.23% | -76.66% | -43.48% | 28.16% |
Accounts Receivable | - | 0.04 | 0.21 | 0.5 | 0.15 |
Other Receivables | 1.5 | 1.07 | 1.02 | 1.66 | 0.5 |
Receivables | 1.5 | 1.11 | 1.23 | 2.16 | 0.65 |
Inventory | 0.08 | 0.1 | 0.2 | 0.18 | 0.18 |
Prepaid Expenses | - | 0.67 | 0.3 | 0.34 | 0.42 |
Other Current Assets | - | 0.53 | 21.49 | 0 | - |
Total Current Assets | 10.64 | 11.83 | 25.91 | 14.17 | 21.59 |
Property, Plant & Equipment | 0.45 | 0.31 | 0.06 | 0 | 0.01 |
Other Intangible Assets | 39.29 | 2.68 | - | - | 0.04 |
Long-Term Deferred Charges | - | 26.59 | 23.18 | 16.71 | 18.57 |
Other Long-Term Assets | 0.48 | 0.57 | 0.07 | 0.07 | - |
Total Assets | 50.86 | 41.97 | 49.22 | 30.95 | 40.2 |
Accounts Payable | - | 2.52 | 9.45 | 2.18 | 1.17 |
Accrued Expenses | - | 3.21 | 2.92 | 1.05 | 0.84 |
Short-Term Debt | - | - | 11.2 | - | - |
Current Portion of Long-Term Debt | - | 0.07 | 0.4 | 0.4 | 0.4 |
Current Income Taxes Payable | - | 0.05 | 0.1 | 0.24 | 0.18 |
Other Current Liabilities | 24.33 | 2.65 | 0.41 | 0.46 | 0.84 |
Total Current Liabilities | 24.33 | 8.5 | 24.48 | 4.33 | 3.43 |
Long-Term Debt | - | - | 0.07 | 0.47 | 0.87 |
Other Long-Term Liabilities | - | - | -0 | -0 | - |
Total Liabilities | 24.33 | 8.5 | 24.55 | 4.8 | 4.3 |
Common Stock | 5.92 | 0.67 | 7.17 | 1.37 | 0.91 |
Additional Paid-In Capital | 211.82 | 183.69 | 177.15 | 149.32 | 130.45 |
Retained Earnings | - | - | - | - | -95.45 |
Comprehensive Income & Other | -191.21 | -150.89 | -159.65 | -124.54 | -0 |
Shareholders' Equity | 26.53 | 33.47 | 24.67 | 26.15 | 35.91 |
Total Liabilities & Equity | 50.86 | 41.97 | 49.22 | 30.95 | 40.2 |
Total Debt | - | 0.07 | 11.67 | 0.87 | 1.27 |
Net Cash (Debt) | 9.07 | 9.35 | -8.99 | 10.62 | 19.06 |
Net Cash Growth | -3.05% | - | - | -44.28% | 32.42% |
Net Cash Per Share | 0.27 | 6.63 | -111.17 | 583.53 | 1348.32 |
Filing Date Shares Outstanding | 59.19 | 6.7 | 0.12 | 0.02 | 0.02 |
Total Common Shares Outstanding | 59.19 | 6.7 | 0.12 | 0.02 | 0.02 |
Working Capital | -13.69 | 3.32 | 1.43 | 9.84 | 18.15 |
Book Value Per Share | 0.45 | 4.99 | 206.55 | 1144.01 | 2379.60 |
Tangible Book Value | -12.76 | 30.79 | 24.67 | 26.15 | 35.87 |
Tangible Book Value Per Share | -0.22 | 4.59 | 206.55 | 1144.01 | 2377.14 |
Machinery | - | 0.78 | 0.56 | 0.73 | 0.73 |